¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"termination sequence"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • epilemmal termination
    ½Å°æ¼Ó¸·Á¾¸», ½Å°æ³»¸·Á¾¸»
  • involuntary termination
    °­Á¦Á¾°á
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¿¬¼â, ¼±Á¾¾ÏÁ¾¿¬¼â
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
  • intervening sequence
    °³Àç¼ø¼­
  • oligohydroamnios sequence
    ¾ç¼ö°ú¼ÒÁõ¿¬¼â
  • pulse sequence
    ¹Úµ¿¿¬¼â, ÆÞ½º¿¬¼â
  • packaging sequence
    ²Ù¸®±â¼ø¼­
  • rapid-sequence induction
    ºü¸¥¿¬¼Ó¸¶ÃëÀ¯µµ
  • rapid-sequence intubation
    ºü¸¥¿¬¼Ó±â°ü»ð°ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    Á¾¸», Á¾·á
  • sequence
    ¼ø¼­, ¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • epilemmal termination
    ½Å°æ¼Ó¸·Á¾¸»
  • involuntary termination
    °­Á¦Á¾°á
  • termination signal
    Á¾·á½ÅÈ£
  • termination
    Á¾¸», Á¾·á
  • adenoma-carcinoma sequence
    »ùÁ¾¾ÏÁ¾¼ø¼­
  • amino acid sequence
    ¾Æ¹Ì³ë»ê¼ø¼­
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüǪ¸®¾îº¯È¯¿¬¼â
  • echo train sequence
    ¿¡ÄÚ¿­¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ±â¿ï±âȸº¹¿¬¼â
  • flow compensated pulse sequence
    È帧º¸»óÆÞ½º¿¬¼â
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • imaging sequence
    ¿µ»ó¿¬¼â
  • insertion sequence
    »ðÀÔ¼­¿­
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Carr Purcell sequence Carr Pursell
    ¿¬¼â
  • DNA sequence analysis
    DNA ¼­¿­ºÐ¼®
  • FID pulse sequence
    ÀÚÀ¯ ºØ±« À¯µµ ÆÞ½º ¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • imaging of STIR sequence
    STIR ¿¬¼â ¿µ»ó
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • insertion sequence, IS
    »ðÀÔ¼­¿­, »ðÀÔ¿ä¼Ò
  • porters sequence
    Æ÷ÅÍ¿¬¼â(¡­ææáð), Æ÷Å͹迭¼ø(¡­ÛÕÖªâ÷)
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • radio-frequency pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
  • reaction sequence
    ¹ÝÀÀ¼ø¼­.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • epilemmal termination
    ½Å°æ³»¸·Á¾¸»(¡­ðûØÇ).
  • involuntary termination
    °­Á¦ Á¾°á
  • termination
    Á¾°á(ðûÌ¿).
  • termination
    Á¾¸»(ðûØÇ).
  • termination signal
    Á¾·á(ðûèç)½ÅÈ£.
  • termination tolerance
    Á¾½Ä°ü¿ë.
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â(àÍðþ-äßðþ ææáð)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê ¼­¿­.
  • breech disruption sequence
  • delta sequence
    µ¨Å¸ ¼­¿­
  • driven equilibrium Fourier transform sequence
    ÃßÁø ÆòÇü Fourier º¯È¯ ¿¬¼â
  • echo train sequence
    ¿¡ÄÚ ¿­ ¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿ º¸»ó ÆÞ½º ¿¬¼â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • chain termination mutation
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) º¯ÀÌ(ܨì¶)
  • termination
    Á¾·á(ðûÖõ)
  • termination codon
    Á¾·á(ðûÖõ)ÄÚµ·
  • termination factor
    Á¾·áÀÎÀÚ (ðûÖõì×í­)
  • Alu sequence
    Alu ¼­¿­(ßíæê)
  • amino acid sequence
    ¾Æ¹Ì³ë»ê(ß«) ¼­¿­(ßíæê)
  • base sequence
    ¿°±â¼­¿­(ç¤ÐñßíÖª)
  • chi sequence
    Ä«ÀÌ ¼­¿­(ßíÖª)
  • complementary base sequence
    »óº¸¼º ¿°±â¼­¿­(ßÓÜÍàõç¤ÐñßíÖª)
  • consensus sequence
    °øÅë¼­¿­(Íì÷×ßíÖª)
  • conserved sequence
    º¸Á¸(ÜÁðí) ¼­¿­(ßíÖª)
  • core sequence
    Çٽɼ­¿­(ú·ãýßíÖª)
  • effector sequence
    È¿°ú±â ¼­¿­(üùÍýÐïßíÖª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    Á¾¸»
  • Carr Purcell sequence
    Carr Pursell¿¬¼â
  • driven equilibrium Fourier transform sequence
    ÃßÁøÆòÇüFourierº¯È¯¿¬¼â
  • echo train sequence
    ¿¡ÄÚ¿­¿¬¼â
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó´Ù¸éȸ¼Õ°æ»çȸº¹¿¬¼â
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • FID pulse sequence
    ÀÚÀ¯ºØ±«À¯µµÆÞ½º¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿º¸»óÆÞ½º¿¬¼â
  • flow sensitive gradient echo sequence
    À¯µ¿¹Î°¨°æ»ç¿¡ÄÚ¿¬¼â
  • gradient echo [=GRE] pulse sequence
    °æ»ç¿¡ÄÚÆÞ½º¿¬¼â
  • gradient echo sequence
    °æ»ç¿¡ÄÚ¿¬¼â
  • imaging of STIR sequence
    STIR¿¬¼â¿µ»ó
  • imaging sequence
    ¿µ»ó¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀüȸº¹ÆÞ½º¿¬¼â
  • mixed sequence
    º¹ÇÕ¿¬¼â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IS ileal segment; immediate sensitivity; immune serum; immunosuppression; impingement syndrome; incenti...
RSI rapid-sequence induction; rapid sequence intubation; repetition strain injury
PT pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t...
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
STOP Study of Hypertension in the Elderly [Sweden] or Swedish Trial in Old Patients with Hypertension; su...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PTC premature termination codon
TOP termination of pregnancy
ACS ARS consensus sequence
ARS Autonomously replicating sequence
EST Expressed Sequence Tag
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • termination
    Á¾¸»
  • thalamic termination
    ½Ã»ó Á¾°á
  • adenoma-carcinoma sequence
    ¼±Á¾-¾ÏÁ¾ ¿¬¼â
  • Carr Purcell sequence
    Carr Pursell ¿¬¼â
  • developmental sequence
    ¹ß´Þ ¼ø¼­
  • fast multiplanar spoiled gradient recalled sequence
    °í¼Ó ´Ù¸é ȸ¼Õ °æ»ç ȸº¹ ¿¬¼â
  • flow compensated pulse sequence
    À¯µ¿ º¸»ó ÆÞ½º ¿¬¼â
  • Fourier acquisition in the steady state sequence
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • imaging sequence
    ¿µ»ó ¿¬¼â
  • inversion recovery pulse sequence
    ¿ªÀü ȸº¹ ÆÞ½º ¿¬¼â
  • pulse sequence
    ¹Úµ¿ ¿¬¼â, ÆÞ½º ¿¬¼â
  • RF pulse sequence
    °íÁÖÆÄ ÆÞ½º ¿¬¼â
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
termination sequence <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
peptide chain termination The process whereby the last amino acid is added to a polypeptide. This termination is signaled by one of three termination triplets in the mRNA, immediately following the last amino acid codon.
(12 Dec 1998)
peptide termination factors Proteins that are exclusively involved in the termination reactions of protein synthesis on the ribosome.
(12 Dec 1998)
termination <molecular biology> Stop of mRNA synthesis (i.e., transcription) at the terminator site
Top of protein synthesis (i.e., translation) at the stop codon.
(09 Oct 1997)
termination codon <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
termination factor <molecular biology> Any of several proteins in the cytosol that cut a completed polypeptide loose from a ribosome.
(13 Jan 1998)
termination region <molecular biology> A DNA sequence that signals the end of transcription.
(13 Jan 1998)
alu sequence Any of a family of short (300 basepairs long) repeated sequences that occur throughout the human genome.
(09 Oct 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
autonomously replicating sequence <molecular biology> This is a chromosomal sequence that allows plasmids to replicate on their own in yeast.
(02 Jan 1998)
base sequence <molecular biology> The order of nucleotide bases in a DNA molecule.
(09 Oct 1997)
base sequence analysis <molecular biology> A method, sometimes automated, for determining the base sequence.
(09 Oct 1997)
canonical sequence Of a series of related DNA, RNA or protein sequences, the sequence that reflects the most common choice of base or amino acid at each position. Areas of particularly good agreement often represent conserved functional domains. The generation of consensus sequences has been subjected to intensive mathematical analysis.
(18 Nov 1997)
carbohydrate sequence The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids.
(12 Dec 1998)
palindromic sequence <molecular biology> Nucleic acid sequence that is identical to its complementary strand when each is read in the correct direction (e.g. TGGCCA). Palindromic sequences are often the recognition sites for restriction enzymes. Degenerate palindromes with internal mismatching can lead to loops or hairpins being formed (as in tRNA).
(18 Nov 1997)
recognition sequence A nucleotide sequence --typically composed of 4, 6, or 8nucleotides -- that is recognised by a restriction endonuclease. Type II enzymes cut (and theircorresponding modification enzymes methylate) within or very near the recognition sequence.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    °á¸»
  • termination
    Á¾°á;¸¸±â;¸»´Ü;ÇѰè
  • sequence
    °è¼ÓÇϱâ
  • insertion sequence
    »ðÀԹ迭
  • nucleotide sequence
    (»ýÈ­)´ºÅ¬·¹¿ÀƼµå ¹è¿­
  • sequence
    ¿¬¼Ó;¼ø¼­;Â÷·Ê;°á°ú;¼ø¼­·Î µÈ µ¿Á¾ÀÇ ÆÐÀÇ ÇÑ Á¶;±Í°á;°á°ú;ÀÕ´Ü;ÀÕ´Þ¾Æ ÀϾ´Â;ÇÊ¿¬ÀûÀÎ °á°ú·Î¼­ ÀϾ´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á